Bandingkan Harga & Kinerja Minna Padi Investama Sekuritas Tbk. (PADI) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Minna Padi Investama Sekuritas Tbk. dan Organon Pharma Indonesia Tbk.: Minna Padi Investama Sekuritas Tbk. diperdagangkan di Rp72 (kapitalisasi pasar 963,38 M, volume 24 jam 101,89 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Minna Padi Investama Sekuritas Tbk. jauh lebih besar — sekitar 9,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PADI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 963,38 M | 104,4 M |
Volume | 101,89 jt | — |
Lot | 1,02 jt | — |
Perputaran | 7,25 M | — |
Harga Rata-rata | 71,12 | — |
Nilai Transaksi | 7,25 M | — |
Harga Ekuilibrium Indikatif | 72 | — |
Volume Ekuilibrium Indikatif | 49,96 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Minna Padi Investama Sekuritas Tbk.
PT Minna Padi Investama Tbk (formerly PT Batavia Artatama Securindo) was established by No Deed. 79 dated May 28, 1998 of Notary Drs. Atrino Leswara, SH. This Deed has been approved by the Ministry of Justice of the Republic of Indonesia in his Decree No. C2-8234.HT 01.01.Th.98 dated July 3, 1998 and was published in the Official Gazette Republic of Indonesia No.. 86 dated October 27, 2006, Supplement. 11489.
Selengkapnya di halaman PADI →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
